Tricuspid regurgitation and heart failure: the faith of treated vs untreated cohort in the percutaneous era

27 August 2023 (17:15 - 18:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Edoardo Zancanaro

University Medical Center of Mainz, Mainz (Germany)

7 More presentations in this session

Presentation thumbnail

Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure

Doctor B. Wang (Galway, IE)

Abstract Slides

Presentation thumbnail

Interventional rhythm control is associated with an improved long-term prognosis of patients with atrial fibrillation undergoing transcatheter edge-to-edge mitral valve repair

Doctor C. Waechter (Muenster, DE)

Abstract Slides Video

Presentation thumbnail

The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study

Doctor C. Paitazoglou (Luebeck, DE)

Abstract Slides Video

Presentation thumbnail

Impact of sacubitril valsartan initiation in patients with HFrEF and severe mitral regurgitation referred for percutaneous mitral repair

Mrs M. Rivadeneira Ruiz (Madrid, ES)

Abstract Slides Video

Presentation thumbnail

A proactive care pathway that improves medical therapy for patients with heart failure with reduced ejection fraction and implantable cardiac devices

Doctor H. Williams (Bristol, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Complex and novel interventions for heart failure

The Event

Event poster

ESC Congress 2023

27 August 2023 17:15 CET

You may be interested in

Congress Session

Navigating through heart failure device therapies

Congress Session

Multidisciplinary approach in heart failure clinic

Congress Session

The strength of scientific integration

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources